This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
5 Specialty Chemical Stocks to Scoop Up on Demand Revival
by Anindya Barman
An upturn in demand across major end-markets such as construction and automotive instills optimism in the specialty chemical space. DQ, ESI, CE, FSI and FOE are worth betting on right now.
Celanese (CE) to Construct LCP Polymerization Plant in China
by Zacks Equity Research
The investment will make Celanese (CE) the only LCP producer with assets in Asian and Western Hemisphere.
Global Chemical Output Leaps for Sixth Straight Month: 5 Picks
by Anindya Barman
The chemical industry has recovered from the pandemic-led slump and looks set for an upturn this year on a rebound in end-market demand. CBT, HUN, CC, PPG and CE to gain from the industry's recovery.
Celanese's (CE) Stock Rallies 40% in 6 Months: Here's Why
by Zacks Equity Research
Celanese (CE) is gaining from its productivity actions, investments in high-return organic projects and strategic acquisitions.
Here's Why You Should Add Celanese (CE) to Your Portfolio
by Zacks Equity Research
Celanese (CE) gains from its productivity measures, investments in high-return organic projects and strategic acquisitions.
Should Value Investors Pick Celanese (CE) Stock Now?
by Zacks Equity Research
Let's see if Celanese (CE) stock is a good choice for value-oriented investors right now from multiple angles.
Here's Why You Should Hold Onto Celanese (CE) Stock for Now
by Zacks Equity Research
Celanese (CE) gains from its productivity actions, investments in high-return organic projects and strategic acquisitions.
Celanese (CE)-Mitsubishi Gas Sign Memorandum of Understanding
by Zacks Equity Research
Celanese (CE) And Mitsubishi Gas sign MOU to restructure the Korea Engineering Plastics JV.
Why Is Celanese (CE) Up 16.4% Since Last Earnings Report?
by Zacks Equity Research
Celanese (CE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Celanese (CE) Up 57% in 6 Months: What's Driving the Stock?
by Zacks Equity Research
Celanese (CE) is gaining from its productivity actions, investments in high-return organic projects and strategic acquisitions.
4 Chemical Specialty Stocks to Escape Industry Challenges
by Anindya Barman
Soft demand amid sluggish industrial activities due to coronavirus clouds prospects for the Zacks Chemicals Specialty industry. Quaker Chemical (KWR), Valvoline (VVV), Element Solutions (ESI) and Ingevity (NGVT) are set to gain from self-help actions.
Celanese (CE) Unveils POM ECO-B to Support Renewable Content
by Zacks Equity Research
Celanese's (CE) latest offering has a strong value proposition for customers in the consumer products, automotive and medical device space.
Celanese (CE) Up 23% in 3 Months: What's Behind the Rally?
by Zacks Equity Research
Forecast-topping earnings performance in the third quarter has contributed to the run-up in Celanese's (CE) shares.
ESI vs. CE: Which Stock Is the Better Value Option?
by Zacks Equity Research
ESI vs. CE: Which Stock Is the Better Value Option?
Celanese's (CE) Earnings and Sales Surpass Estimates in Q3
by Zacks Equity Research
Celanese's (CE) Engineered Materials unit in Q3 witnesses strong demand recovery for durable goods across all regions.
Huntsman (HUN) Gains on Downstream Investment, Acquisitions
by Zacks Equity Research
Huntsman (HUN) gains on actions to grow its downstream specialty and formulation businesses and synergies of strategic acquisitions.
Celanese (CE) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Benefits from productivity actions amid demand weakness are likely to get reflected in Celanese's (CE) third-quarter 2020 results.
Celanese (CE) Raises Prices of Engineered Materials Products
by Zacks Equity Research
Per Celanese (CE), the price hike is due to a substantial increase in demand for its specialty polymer products.
Celanese Wraps Divestment of Stake in Polyplastics to Daicel
by Zacks Equity Research
Celanese (CE) plans to deploy the proceeds from the transaction to higher value-generating opportunities.
Eastman Chemical (EMN) Inks Distribution Deal With DKSH
by Zacks Equity Research
Eastman Chemical's (EMN) latest collaboration will help it create value for customers through faster innovation and commercialization.
Eastman Chemical Gains on Cost-Cut Actions Amid Soft Demand
by Zacks Equity Research
While Eastman Chemical (EMN) is exposed to a weak demand environment, it will gain from innovation and cost-reduction measures.
Celanese (CE) Up 34% in 6 Months: What's Behind the Rally?
by Zacks Equity Research
Celanese (CE) gains from productivity actions, investments in high-return projects and strategic acquisitions.
Celanese Increases Selling Prices of Acetyl Intermediates
by Zacks Equity Research
Celanese's (CE) latest price increase is applicable for orders shipped and is immediately effective or as contracts permit.
Celanese (CE) Gains on Productivity Actions Amid Soft Demand
by Zacks Equity Research
Celanese (CE) benefits from productivity improvement actions, acquisitions and investments in high-return organic projects.
Celanese (CE) Up 5.8% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Celanese (CE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.